{"organizations": [], "uuid": "6435937efebd5ea58ab572669ab0504119a9e8d9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180301.html", "section_title": "Archive News &amp; Video for Thursday, 01 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fibrogen-granted-fast-track-design/brief-fibrogen-granted-fast-track-designation-by-u-s-fda-for-pamrevlumab-treatment-of-patients-idUSASB0C89K", "country": "US", "domain_rank": 408, "title": "Fibrogen Granted Fast Track Designation By U.S. FDA For Pamrevlumab Treatment Of Patients", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.215, "site_type": "news", "published": "2018-03-01T20:17:00.000+02:00", "replies_count": 0, "uuid": "6435937efebd5ea58ab572669ab0504119a9e8d9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fibrogen-granted-fast-track-design/brief-fibrogen-granted-fast-track-designation-by-u-s-fda-for-pamrevlumab-treatment-of-patients-idUSASB0C89K", "ord_in_thread": 0, "title": "Fibrogen Granted Fast Track Designation By U.S. FDA For Pamrevlumab Treatment Of Patients", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "fibrogen inc", "sentiment": "negative"}, {"name": "fibrogen", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 1 (Reuters) - Fibrogen Inc:\n* FIBROGEN GRANTED FAST TRACK DESIGNATION BY U.S. FDA FOR PAMREVLUMAB TREATMENT OF PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER Source text for Eikon: (Reuters.Brief@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-01T20:17:00.000+02:00", "crawled": "2018-03-02T19:59:50.000+02:00", "highlightTitle": ""}